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The ad~nistration to rats of either t-butyl hydro~roxide or phenobarbital, compounds that are metabo- 
lized through detoxification processes, produces au increase in specific activity of the NADPH-consuming 
enzymes, giutathione reductase and NADR~~yt~hrorn~ c reductase. These compounds also produce a 
very significant increase in the specific activity of mahc enzyme. Immunopr~ipitation with a specific anti- 
body for malic enzyme indicates that specific activity changes are the result of corresponding changes in 
the amounts of enzyme protein present. The administration of 1,3-bis(chloroethyl(-I-nitrosourea ( gluta- 
thione reductase inhibitor) together with t-butyl hydro~roxide abolishes any stimuIation of malic enzyme 
activity. These results indicate that an increase in NADPH consumption induces the synthesis of malic en- 
zyme. Alternatively, a protection of enzyme degradation cannot be rigorously excluded. 
f . INTRODUCTION 
The participation of malic e~2y~~ in the genera- 
tion of reducing equivalents as NADPH has been 
demonstrated experimentally under a number of 
different conditions [l-3]. In many of these situa- 
tions, the activity of maiic enzyme and the rate of 
fatty acid synthesis are highly correlated in several 
animal systems [4-61. This correlation between 
fatty acid synthesis and the activity of maIic en- 
zyme, one of whose functions include that of pro- 
viding NADPH for ‘de novo’ fatty acid synthesis, 
could suggest that the activity of ma&c enzyme 
could be regulated by the NADPH/NADP+ ratio 
through a mechanism involving changes in the 
NADPH requirement. In this way, an increase or 
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I,3-Bis(chloroeth--I-nitrosourea 
decrease in NADPH requirement wouid respec- 
tively produce the increase or decrease in the 
amount of malic enzyme. 
Here, we have studied the effect of changes in 
the flux through different NADP~-consumjng 
pathways on the synthesis and activity of mahc en- 
zyme. We have examined firstly the effect of 
xenobiotics compounds [Gbutyi hydroperoxide (t- 
BHP) and phenobarbital (PB)] which are 
metabolized through detoxification processes 
which use the NADPH : glutath~one peroxidase- 
glutathione reductase system f7] and NADPH- 
cytochrome P-450 reductase [8] and secondly the 
effect of administration of 1,3-bis(chloroethyI)- 
l-n~trosourea (BCNU) an inbibjtor of gl~tathione 
reductase [9] in conjunction with that of t-BHP. 
The results show that an increase in the con- 
sumption of NADPH is paralleled by an increase 
in the synthesis, hence in specific activity of mahc 
enzyme and that when the increase in NADPH 
consumption is prevented, the malic enzyme Ievet 
does not change. 
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2. MATERIALS AND METHODS 
2.1. Animals 
Female rats of the Wistar strain weighing 
150-250 g were used. They were maintained on a 
standard laboratory diet. Rats described as fasted- 
refed were deprived of food for 48 h and then 
allowed free access for the next 48 h to a 
carbohydrate-rich diet. 
2.2. Treatment 
The following compounds were administered: t- 
BHP, 25 mg-kg-’ i.p. daily for 3 days; PB, 
70 mg. kg-’ i.p. daily for 4 days; BCNU, 
40 mg. kg -’ i.p. daily for 3 days. 
2.3. Chemicals 
All enzymes and coenzymes were purchased 
from Sigma (USA) and Boehringer (FRG). BCNU 
was obtained from Bristol Laboratories (USA). All 
other chemicals were of the highest purity available 
from commercial sources. 
2.4. Preparation of tissue extracts 
Rats were killed by cervical dislocation and the 
liver and adipose tissue immediately removed and 
homogenized in 7 vols ice-cold medium containing 
0.25 M sucrose, 1 mM EDTA, 1 mM DTT and 
15 mM Tris-HCl, pH 7.4. The homogenate was 
centrifuged at 800 x g for 10 min. The supernatant 
fraction (supernatant 1) was then centrifuged for 
10 min at 8200 x g and the supernatant obtained 
was recentrifuged for 15 min at 11500 x g. The 
postmitochondrial supernatant fraction was cen- 
trifuged at 105000 x g for 60 min and the pellet 
(microsomal fraction) resuspended in the buffer 
described above. 
2.5. Measurements of enzyme activities 
Malic enzyme was assayed by the method of 
Ochoa et al. [lo]. Glutathione reductase was deter- 
mined as described by Wdthington and Rosemeyer 
[ 111. NADPH-cytochrome c reductase was assayed 
by the method of Vermilion and Coon [12]. En- 
zyme activities are expressed as nmol of 
NADPH . mg protein-‘. min-r . All assays were 
carried out in supernatant 1, except for hepatic 
NADPH-cytochrome c reductase, whose activity 
was determined in the microsomal fractions. Pro- 
teins were determined by the method of Lowry et 
al. [13]. 
2.6. Purification of malic enzyme 
The enzyme was purified from fasted-refed rat 
liver. The method used was basically that of F- 
Lobato et al. [14] but in the last step of the process 
the L-malato-AH Sepharose 4B affinity 
chromatography column was replaced by a column 
of NADP-agarose (5 ml) equilibrated with 50 mM 
Tris-HCI, 10% glycerol. Under these conditions, 
the enzyme was bound to the column and eluted at 
the end of a O-0.02 mM linear gradient of NADP 
made in equilibration buffer. 
A single protein band was obtained when 
samples (25-5Opg) were analysed by 7.5% (w/v) 
polyacrylamide gel electrophoresis in the presence 
of SDS by the method of Maize1 [15]. 
2.7. Preparation of antibodies 
Antiserum to the enzyme was prepared by pure 
enzyme inoculation of female New Zealand rabbits 
by the technique of Chauser [16]. The y-globulin 
fraction was obtained by two consecutive 
precipitations with ammonium sulfate (40% 
saturation), followed by dialysis against 10 mM 
sodium phosphate buffer, pH 7.2, containing 
15 mM NaCl. 
2.8. Immunoprecipitation of the malic enzyme 
activity 
The supernatant obtained by centrifugation at 
105000 x g was used in all the immunoprecipita- 
tion assays. Increasing volumes of antiserum were 
added to a fixed amount of malic enzyme (50 mu) 
from crude extract, the mixture adjusted to a con- 
stant volume with 150 mM NaCl and Triton X-100 
added to a final concentration of 1.7% (w/v). The 
mixtures were allowed to react for 1 h at 37”C, 
overnight at 4°C and then centrifuged at 12000 x 
g for 10 min at 4°C. Samples of the supernatants 
were assayed for malic enzyme activity. 
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3. RESULTS 
3.1. Effect of the variation of NADPH 
consumption, caused by the administration of 
xenobiotic substances, on the enzymatic 
activities of malic enzyme, glutathione 
reductase and NADPH-cytochrome c 
reductase of rat liver 
In our experiments, NADPH consumption has 
been increased by the administration of different 
substances which are metabolized through detox- 
ification processes which use NADPH: (i) t-BHP, 
whose metabolism is mediated by the glutathione 
peroxidase-glutathione reductase system [7] and 
(ii) PB, which is metabolized through NADPH- 
cytochrome P-450 reductase [S]. 
NADPH-cytochrome c reductase of rat liver when 
the animals were treated with the above com- 
pounds. As shown, the administration of t-BHP 
produces a significant increase in the specific ac- 
tivities of the NADPH-consuming enzymes 
glutathione reductase and NADPH-cytochrome c 
reductase. Similar but more marked results are ob- 
tained when PB is used. However, in (t- 
BHP + BCNU)-treated rats, the specific activity of 
NADPH-cytochrome c reductase is not increased 
and that of glutathione reductase is markedly 
diminished, as expected, due to the inhibitory ef- 
fect of BCNU on glutathione reductase activity [9]. 
At the same time, it can be observed that BCNU 
prevents the increase in specific activity of malic 
enzyme that is produced by t-BHP. 
At the same time, inhibition of NADPH- Fig. la represents immunoprecipitation of the 
consuming pathways has been carried out using hepatic malic enzyme of rats treated as described 
BCNU, an inhibitor of glutathione reductase [9]. above. The results show that the amount of malic 
In table 1 are summarized the specific activities enzyme present is proportional to the enzymatic 
of malic enzyme, glutathione reductase and activity found under these situations since the gra- 
Table 1 
Effects of t-BHP, t-BHP + BCNU and PB on specific activities of malic enzyme, glutathione 
reductase and NADPH-cytochrome c reductase in rat liver and adipose tissue 
Tissue Treatment Malic enzyme Glutathione NADPH-cyto- 
reductase chrome c reductase 
Liver control 8.9 2 0.35 57.3 f 7.6 115.3 k 7.1 
(19) (9) (7) 
t-BHP 15.5 + 1.8a 65.6 + 4.3a 152.2 + 8.8” 
(7) (6) (6) 
t-BHP + BCNU 5.9 + 2.7ab 21.5 + 5.7ab 125.5 k 9.8ab 
(5) (5) (5) 
PB 28.3 + 1.3” 80.8 + 3.2a 208.0 f 12.2” 
(6) (6) (6) 
Adipose tissue control 172.9 + 23.1 53.9 + 2.9 13.9 * 0.9 
(10) (7) (9) 
t-BHP 305.5 + 63.3’ 66.4 -t 9.8a 13.1 k 0.7 
(4) (4) (4) 
t-BHP + BCNU 55.3 f 11.5ab 4.6 k l.3db 7.9 + 1.3ab 
(4) (4) (4) 
PB 279.6 + 32.7a 56.0 + 1.7 19.7 + 7.4a 
(4) (4) (4) 
a p < 0.05 
b Compared with t-BHP-treated rats 
Enzyme activities were measured as indicated in section 2. Results are given in mU/mg protein 
as means f SE for the number of animals in parentheses 
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Fig. 1. Immunoprecipitation of malic enzyme of liver (a) 
and of adipose tissue (b). A fixed amount of mahc 
enzyme (50 mu) was incubated with increasing volumes 
of antiserum as described in section 2. Enzyme activity 
remaining in the supernatant is represented as mu. Each 
data point corresponds to 3 individual experiments. (0) 
Control, (A) t-BHP-treated rats, (0) (t-BHP + BCNU)- 
treated rats, (0) PB-treated rats. 
dients remain constant under the different condi- 
tions assayed. These results indicate that the in- 
crease in specific activity of this enzyme by t-BHP 
and PB is caused by an increase in synthesis of the 
enzyme or its protection against degradation. 
3.2. Effect of 
consumption 
tissue 
The effects of 
zymatic activities 
the variation of NADPH 
on enzyme activities in adipose 
xenobiotic substances on en- 
in adipose tissue are listed in 
table 1 and fig.lb. As shown, the specific activity 
of NADPH-cytochrome c reductase is lower than 
in liver; this presumably relates to the fact that 
liver has a major detoxification capacity. The 
specific activity of the enzyme in adipose tissue is 
increased slightly by PB and its activity is 
significantly reduced by BCNU. In this tissue, 
however, the specific activity of glutathione reduc- 
tase is only increased by t-BHP. This effect is due 
to the fact that t-BHP is metabolized through GSH 
oxidation [7] as also occurs in liver. At the same 
time, as expected, BCNU produces a great 
decrease in activity of this enzyme. This result 
represents the specific effect of BCNU on 
glutathione reductase. 
With respect o malic enzyme, the behaviour of 
this enzyme in adipose tissue parallels that found 
in liver: t-BHP and PB produce a significant in- 
crease in its specific activity and BCNU abolishes 
the action of t-BHP. 
Fig. 1 b shows the immunoprecipitation of malic 
enzyme in adipose tissue using the same conditions 
described for liver. As can be seen, the activity of 
malic enzyme is dependent upon the amount of 
protein present. As considered previously, protec- 
tion by xenobiotics against degradation of malic 
enzyme remains a possibility. These results again 
indicate that t-BHP and PB are likely to induce 
synthesis of this enzyme and that BCNU prevents 
this effect. 
4. DISCUSSION 
Taking into account our results, we suggest hat 
if an increase in NADPH requirement is common 
to most metabolic conditions which cause an in- 
duction of malic enzyme, then another metabolic 
situation which also involves increased consump- 
tion of NADPH will produce induction of this en- 
zyme as well. 
In these experiments, we have produced an in- 
crease of NADPH requirement with the ad- 
ministration of substances which are metabolized 
through detoxification processes which use 
NADPH: t-BHP and PB. When these substances 
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were administered, there was an increase of 
glutathione reductase and NADPH-cytochrome c 
reductase, both NADPH-consuming enzymes. 
These results were more significant in liver (table 
1). At the same time, these substances produced a 
very significant increase of malic enzyme activity 
in both tissues assayed (table 1). This corresponds 
with the increase of enzymatic protein (fig.la,b). 
Consequently, these results are in support of t- 
BHP and PB, which produce the increase of 
NADPH requirements, producing an increase in 
the amount of malic enzyme. 
This result is strongly supported by the BCNU 
effect. The administration of BCNU at the same 
time as t-BHP prevents the increase of NADPH re- 
quirements that takes place with t-BHP alone (this 
is due to the inhibition of glutathione reductase). 
When both compounds are administered together 
the increase of malic enzyme is prevented, 
probably due to a decrease in NADPH consump- 
tion caused by BCNU. 
The major effect found in adipose tissue could 
be due to the strong inhibition of NADPH- 
consuming enzymes by BCNU: it produces a 
decrease of one order of magnitude in glutathione 
reductase and NADPH-cytochrome c reductase ac- 
tivity in (t-BHP + BCNU)-treated rats is 50% of 
the activity seen in rats treated with t-BHP alone. 
BCNU could have another effect, since the in- 
crease of GSSG under these conditions could pro- 
duce the inhibition of protein synthesis [17]. To 
establish that this effect was not responsible for the 
results found, we have measured the effect of 
BCNU on malic enzyme of fasted-refed rats. In 
this situation there is an increase in the activity of 
this enzyme and BCNU does not affect the 
NADPH consuming pathway (fatty acid syn- 
thesis). In this case, BCNU does not prevent the 
malic enzyme induction (control, 8.9 f 0.35; 
fasted-refed rats, 22.1 -t 4.6; fasted-refed rats + 
BCNU, 20.2 f 3.04). 
All these results support, to a great extent, the 
theory that the increase of NADPH requirements 
could be a factor implicated in the induction of 
malic enzyme. 
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